<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04397094</url>
  </required_header>
  <id_info>
    <org_study_id>FDASU-Rec ID 101612</org_study_id>
    <nct_id>NCT04397094</nct_id>
  </id_info>
  <brief_title>Theracal Pulpotomy in Primary Molars</brief_title>
  <official_title>Theracal Versus Formocresol Pulpotomy in Primary Molars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol
      pulpotomy in primary molars.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      sixty primary molars were either treated with Theracal LC or formocresol pulpotomy. Teeth
      were followed up clinicaly and radiographically for 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">March 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 17, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical examination</measure>
    <time_frame>12 months</time_frame>
    <description>any adverse clinical outcome related to the treated teeth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic examination</measure>
    <time_frame>12 months</time_frame>
    <description>any adverse radiographic changes related to treated teeth</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Deep Caries</condition>
  <arm_group>
    <arm_group_label>Theracal LC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Theracal LC was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Formocresol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Formocresol was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Theracal LC</intervention_name>
    <description>pulpotomy</description>
    <arm_group_label>Theracal LC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Formocresol</intervention_name>
    <description>Pulpotomy</description>
    <arm_group_label>Formocresol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy, cooperative children

          -  mandibular primary molars with vital pulp exposures

        Exclusion Criteria:

          -  clinical or radiographic evidence of irreversible pulpitis

          -  physiological root resorption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Dentistry, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>1156</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 17, 2020</last_update_submitted>
  <last_update_submitted_qc>May 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mariem Wassel</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Theracal</keyword>
  <keyword>formocresol</keyword>
  <keyword>pulpotomy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>June 21, 2020</submitted>
    <returned>July 8, 2020</returned>
    <submitted>July 11, 2020</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

